Tevogen TVGN
NASDAQ TVGN
$7.29 -0.05 (-0.68%)
At close: Sep 10, 2026 · 4:00 PM EDT

Tevogen (TVGN) Current Leases (2023 - 2026)

Tevogen's (TVGN) quarterly Current Leases came in at $327740.0 in Q1 2026, up 91.83% on a YoY basis from $170851.0 in Q1 2025, and little changed quarter-over-quarter from $327740.0 in Q4 2025.

Analysis

Tevogen (TVGN) Current Leases (2023 - 2026) Analysis & Trends

Tevogen (TVGN) has reported Current Leases for 4 consecutive years, with $327740.0 the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Current Leases rose 91.83% year-over-year to $327740.0; the trailing twelve-month figure through Mar 2026 stood at $327740.0 (up 91.83% YoY), and the FY2025 full-year result was $327740.0, up 43.08% from the prior year.
  • Current Leases steadied at $327740.0 in Q1 2026 per TVGN's latest filing, from $327740.0 in the prior quarter.
  • Across five years, Current Leases topped out at $327740.0 in Q2 2025 and bottomed at $170851.0 in Q1 2025.
  • Historically, Current Leases has averaged $275135.0 across 4 years, with a median of $264627.5 in 2024.
  • The sharpest annual moves came in 2025 and 2026: Current Leases sank 34.44% in 2025, then surged 91.83% in 2026.
  • Over 4 years, Current Leases stood at $252714.0 in 2023, then declined by 9.36% to $229063.0 in 2024, then jumped by 43.08% to $327740.0 in 2025, then changed by 0.0% to $327740.0 in 2026.
  • According to Business Quant data, Current Leases over the past three periods registered $327740.0, $327740.0, and $327740.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Krystal Biotech 10.21 Bn 9.37 Bn 112.79 Mn 1.81 Mn
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - 18.65 Mn
3 Iovance Biotherapeutics 3.65 Bn 3.36 Bn 55.72 Mn 2.67 Mn
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn -
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 2.99 Mn
6 Beam Therapeutics 2.55 Bn 2.55 Bn - 15.21 Mn
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn 1.06 Mn
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn -
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn 14.16 Mn
10 Tevogen 27.76 Mn 27.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 327,740.00
Dec 31, 2025 327,740.00
Sep 30, 2025 327,740.00
Jun 30, 2025 327,740.00
Mar 31, 2025 170,851.00
Dec 31, 2024 229,063.00
Sep 30, 2024 258,507.00
Jun 30, 2024 268,672.00
Mar 31, 2024 260,583.00
Dec 31, 2023 252,714.00